Sunshine Heart (CHFS) Shares Down 10.8%

Sunshine Heart Inc (NASDAQ:CHFS) was down 10.8% during trading on Wednesday . The stock traded as low as $3.65 and last traded at $3.70. Approximately 853,100 shares traded hands during mid-day trading, an increase of 3% from the average daily volume of 830,333 shares. The stock had previously closed at $4.15.

Several equities research analysts have commented on CHFS shares. Zacks Investment Research upgraded shares of Sunshine Heart from a “hold” rating to a “buy” rating and set a $4.00 price target on the stock in a research note on Monday. ValuEngine lowered shares of Sunshine Heart from a “sell” rating to a “strong sell” rating in a research note on Monday, October 2nd.

The firm has a market capitalization of $6.48, a P/E ratio of -0.02 and a beta of 2.25.

TRADEMARK VIOLATION WARNING: “Sunshine Heart (CHFS) Shares Down 10.8%” was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.com-unik.info/2018/01/12/sunshine-heart-chfs-shares-down-10-8.html.

About Sunshine Heart

CHF Solutions, Inc, an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.

Receive News & Ratings for Sunshine Heart Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sunshine Heart and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit